This Speaker Series is a summary of a recent speaker event titled: Vanzacaftor/tezacaftor/deutivacaftor – A next-generation highly effective CFTR modulator.
This presentation was given by Dr Tavs Qvist, an ID Specialist & Researcher from the Copenhagen Cystic Fibrosis Centre in Denmark. Dr Qvist discusses the experience of the roll out of CFTR modulators in Denmark
Please login below to download this issue (PDF)